Viral Infections
EU HEPATITIS PARTNER
US HEPATITIS PARTNER
US Partner
An Introduction to Viral Infections
Viruses are intracellular parasites, and are the most widespread organisms on Earth. They cause acute disease, such as gastroenteritis or influenza, or chronic disease, such as HIV or hepatitis. Emerging infections, such as SARS, MERS, avian influenza, Ebola and most recently, the devastating SARS-Cov-2 pandemic pose an increasing threat to human health. Numerous substances with antiviral activity are in clinical use. The use of protease inhibitors and highly active antiretroviral therapy has transformed the management of HIV. Promising emerging therapeutic approaches include neutralising antibodies. In addition, the current success of mRNA vaccines against SARS-Cov-2 heralds a new era of vaccinology. However, the threat of drug- and vaccine-resistant viral mutants are a major problem.
Expert video highlights and insights from the conference hub and comprehensive peer-reviewed articles from our journal portfolio provide updates on the changing treatment landscape. To learn more about how the latest developments impact on patient outcomes view our expert-led learning activities.
Our supporting partners do not constitute an endorsement of the content on this page.
